Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 135INDUSTRY 13NETWORK 5NIH 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Head & Neck 1

Conditions

Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 116Magnetic Resonance Spectroscopy 77Biopsy 71Cyclophosphamide 24pembrolizumab 22Cisplatin 21fludarabine 18Platinum 171,2-diaminocyclohexaneplatinum II citrate 17Taxes 16Paclitaxel 16Carboplatin 16Nivolumab 15Immunoglobulin G 15Disulfides 15X-Rays 13Radiation 13venetoclax 12Doxorubicin 12Radiotherapy 11Gemcitabine 11durvalumab 10Prednisone 9cabozantinib 8aldesleukin 8olaparib 7decitabine and cedazuridine drug combination 7atezolizumab 7Cytarabine 7lutetium Lu 177 dotatate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × NIH × Standard of Care × Clear all
NCT05564390 2026-05-26

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

National Cancer Institute (NCI)

Phase 2 Recruiting
2,000 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT07260344 2026-04-14

Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral Precancer

National Institutes of Health Clinical Center (CC)

Phase NA Recruiting
400 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡